SynthesisPloS one2012

Combined EGFR and VEGFR versus single EGFR signaling pathways inhibition therapy for NSCLC: a systematic review and meta-analysis.

Xinji Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.